MoonLake Immunotherapeutics
MLTX
#5586
Rank
A$1.86 B
Marketcap
A$25.34
Share price
-1.52%
Change (1 day)
-57.30%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2025 (TTM): -A$0.34 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -A$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2025

Annual earnings

Year Earnings Change
2025 -A$0.31 Billion79.14%
2024 -A$0.18 Billion129.45%
2023 -A$75.41 Million-16.81%
2022 -A$90.65 Million